XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Net income $ 43,935 $ 75,464
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,025 3,462
Provision/ (credit) for credit losses 1,635 (34,708)
Share based compensation expense 1,472 947
Deferred income tax expense 4,177 9,125
Origination of loans held for sale (104,823) (536,747)
Proceeds from sales of loans held for sale 129,389 540,736
Gains on sales of loans held for sale (2,694) (10,625)
Investment securities gains (8) (58)
Tax benefit associated with share based compensation (245) 426
Net decrease in accrued interest receivable 821 1,872
Net (increase)/ decrease other assets 7,054 (9,461)
Net decrease in accrued expenses and other liabilities (16,433) (12,786)
Other, net (2,201) 370
Net cash provided by operating activities 65,104 28,017
Investing activities:    
Sales of equity securities 9 20,913
Purchases of investments available-for-sale (232,295) (280,942)
Proceeds from sales of investment available-for-sale 1,261 100,822
Proceeds from maturities, calls and principal payments of investments available-for-sale 68,818 99,668
Proceeds from maturities, calls and principal payments of investments held-to-maturity 4,318 0
Net increase in loans (174,046) (37,247)
Sales of/ (expenditures for) premises and equipment (3,440)  
Sales of/ (expenditures for) premises and equipment   420
Net cash used in investing activities (335,375) (96,366)
Financing activities:    
Net increase in deposits 228,654 646,196
Net decrease in in retail repurchase agreements and federal funds purchased (10,302) (353,839)
Repayment of FHLB advances 0 (279,075)
Proceeds from issuance of subordinated debt 200,000 0
Proceeds from issuance of common stock 800 2,072
Stock tendered for payment of withholding taxes (629) (205)
Dividends paid (15,446) (15,182)
Net cash provided by/ (used in) financing activities 403,077 (33)
Net increase/ (decrease) in cash and cash equivalents 132,806 (68,382)
Cash and cash equivalents at beginning of period 420,020 297,003
Cash and cash equivalents at end of period 552,826 228,621
Supplemental disclosures:    
Interest payments 5,784 11,533
Income tax payments $ 0 $ 22,276